Zoë Y G J van Lierop (Zygj van Lierop, Zoë Ygj van Lierop, Zoë Ygj Van Lierop, Zoë Y G van Lierop)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Topics

Cerebrospinal Fluid

Disease Activity

Multiple Sclerosis

Top Venues

Multiple sclerosis (Houndmills, Basingstoke, England)

Multiple sclerosis journal - experimental, translational and clinical

Clinical chemistry and laboratory medicine

Neurology(R) neuroimmunology & neuroinflammation

This page only lists publications with an associated author ORCID identifier.

Publications

Mark Hj Wessels, Zoë Y G J van Lierop, Samantha Noteboom, Eva M M Strijbis, Johannes A Heijst, Zoé Léonie Elise van Kempen, Bastiaan Moraal, Frederik Barkhof, Bernard Mj Uitdehaag, Menno Michiel Schoonheim, Joep Killestein, Charlotte E Teunissen
Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Zoë Y G J van Lierop, Inge M W Verberk, Kees W J van Uffelen, Marleen J A Koel-Simmelink, Lisanne In 't Veld, Joep Killestein, Charlotte E Teunissen
Pre-analytical stability of serum biomarkers for neurological disease: neurofilament-light, glial fibrillary acidic protein and contactin-1. Clinical chemistry and laboratory medicine 60 (6) (2022)
Zoë Y G J van Lierop, Samantha Noteboom, Martijn D Steenwijk, Maureen van Dam, Alyssa A Toorop, Zoé LE van Kempen, Bastiaan Moraal, Frederik Barkhof, Bernard Mj Uitdehaag, Menno Michiel Schoonheim, Charlotte E Teunissen, Joep Killestein
Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 28 (14) (2022)
Zoë Y G J van Lierop, Luuk Wieske, Marleen Ja Koel-Simmelink, Madhurima Chatterjee, Iris Dekker, Cyra E Leurs, Eline Aj Willemse, Bastiaan Moraal, Frederik Barkhof, Filip Eftimov, Bernhard Mj Uitdehaag, Joep Killestein, Charlotte E Teunissen
Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (2021)
Zoë Y G J van Lierop, A A Toorop, Eline Me Coerver, Eaj Willemse, Emm Strijbis, N F Kalkers, B Moraal, Frederik Barkhof, C E Teunissen, J Killestein, Zle van Kempen
Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients. Multiple sclerosis journal - experimental, translational and clinical 7 (2) (2021)
Claire Bridel, Cyra E Leurs, Zoë Y G J van Lierop, Zoé L E van Kempen, Iris Dekker, Harry A M Twaalfhoven, Bastiaan Moraal, Frederik Barkhof, Bernard M J Uitdehaag, Joep Killestein, Charlotte E Teunissen
Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis. Neurology 97 (19) (2021)
Zoë Y G J van Lierop, Alyssa A Toorop, Wouter Jc van Ballegoij, Tom Bg Olde Dubbelink, Eva Mm Strijbis, Brigit A de Jong, Bob W van Oosten, Bastiaan Moraal, Charlotte E Teunissen, Bernard Mj Uitdehaag, Joep Killestein, Zoé LE van Kempen
Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic. Multiple sclerosis (Houndmills, Basingstoke, England) (2021)
Alyssa A Toorop, Zoë Y G J van Lierop, Eva M M Strijbis, Charlotte E Teunissen, Axel Petzold, Mike P Wattjes, Frederik Barkhof, Brigit A de Jong, Zoé Léonie Elise van Kempen, Joep Killestein
Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab. Neurology(R) neuroimmunology & neuroinflammation 8 (1) (2020)